Content validity of the EORTC quality of life questionnaire QLQ-C30 for use in cancer.

[1]  D. Osoba,et al.  The EORTC Core Quality-of-Life Questionnaire: Interim Results of an International Field Study * , 2021, Effect of Cancer on Quality of Life.

[2]  M. King,et al.  Perceived benefits and limitations of using patient-reported outcome measures in clinical practice with individual patients: a systematic review of qualitative studies , 2021, Quality of Life Research.

[3]  N. Aaronson,et al.  An international update of the EORTC questionnaire for assessing quality of life in breast cancer patients: EORTC QLQ-BR45. , 2020, Annals of oncology : official journal of the European Society for Medical Oncology.

[4]  J. Beaumont,et al.  Does recall period matter? Comparing PROMIS® physical function with no recall, 24-hr recall, and 7-day recall , 2019, Quality of Life Research.

[5]  Christophe Letellier,et al.  Two-Year Survival Comparing Web-Based Symptom Monitoring vs Routine Surveillance Following Treatment for Lung Cancer , 2019, JAMA.

[6]  E. Basch,et al.  Implementation of Patient-Reported Outcomes in Routine Medical Care. , 2018, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.

[7]  J. Reijneveld,et al.  The Use of The Eortc Item Library To Supplement Eortc Quality of Life Instruments , 2017 .

[8]  M. Kris,et al.  Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment , 2017, JAMA.

[9]  J. Heimans,et al.  Evaluation of the psychometric properties of the EORTC chemotherapy-induced peripheral neuropathy questionnaire (QLQ-CIPN20) , 2017, Quality of Life Research.

[10]  Deborah Schrag,et al.  Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  A. Shields,et al.  Telephone Versus face-to-face Interviews for Patient-Reported Outcome Instrument Development. , 2015, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[12]  G. Velikova,et al.  Use of patient-reported outcomes to measure symptoms and health related quality of life in the clinic. , 2015, Gynecologic oncology.

[13]  Adam B. Smith,et al.  Content validity and legacy patient-reported outcome measures in cancer , 2015, Quality of Life Research.

[14]  Carolyn M. Reilly,et al.  Recommended patient-reported core set of symptoms to measure in adult cancer treatment trials. , 2014, Journal of the National Cancer Institute.

[15]  Roma Maguire,et al.  What is the value of the routine use of patient-reported outcome measures toward improvement of patient outcomes, processes of care, and health service outcomes in cancer care? A systematic review of controlled trials. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  N. Gale,et al.  Using the framework method for the analysis of qualitative data in multi-disciplinary health research , 2013, BMC Medical Research Methodology.

[17]  U. S. Department of Health and Human Services FDA Cen Research,et al.  Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance , 2006, Health and quality of life outcomes.

[18]  G. Guest,et al.  How Many Interviews Are Enough? An Experiment with Data Saturation and Variability , 2005 .

[19]  D. Osoba,et al.  Modification of the EORTC QLQ-C30 (version 2.0) based on content validity and reliability testing in large samples of patients with cancer , 1997, Quality of Life Research.

[20]  P. Fayers,et al.  A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients. EORTC Quality of Life Group. , 2000, European journal of cancer.

[21]  S. Haynes,et al.  Content validity in psychological assessment: A functional approach to concepts and methods. , 1995 .

[22]  D. Osoba,et al.  The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. , 1993, Journal of the National Cancer Institute.

[23]  N. Aaronson,et al.  A modular approach to quality-of-life assessment in cancer clinical trials. , 1988, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.